Scientists are turning embryonic stem cells into the retinal cells that are malfunctioning and dying in age-related macular degeneration (AMD). These retinal cells can be implanted into the back of the eye to determine if this will help slow the vision loss caused by AMD.
Scientists are using stem cells to support and restore the light-sensing cells in the eye that degenerate and die in retinitis pigmentosa (RP). These fresh cells can be implanted into the back of the eye to see if this will help slow the vision loss caused by RP.
Type 1 Diabetes (T1D) develops when the body’s own immune system destroys the cells in the pancreas that make insulin. Since T1D patients cannot make their own insulin, they must take insulin multiple times daily to survive. In theory, embryonic stem cells can become any kind of cell type in the body, including cells that produce insulin, and could replace the ones that are destroyed in T1D. Scientists are working on perfecting this technique now.